全文获取类型
收费全文 | 1380606篇 |
免费 | 98204篇 |
国内免费 | 5301篇 |
专业分类
耳鼻咽喉 | 20267篇 |
儿科学 | 40803篇 |
妇产科学 | 39215篇 |
基础医学 | 192839篇 |
口腔科学 | 40589篇 |
临床医学 | 117381篇 |
内科学 | 269835篇 |
皮肤病学 | 31122篇 |
神经病学 | 109187篇 |
特种医学 | 55770篇 |
外国民族医学 | 442篇 |
外科学 | 213024篇 |
综合类 | 36274篇 |
现状与发展 | 10篇 |
一般理论 | 440篇 |
预防医学 | 94841篇 |
眼科学 | 32635篇 |
药学 | 104786篇 |
22篇 | |
中国医学 | 5525篇 |
肿瘤学 | 79104篇 |
出版年
2018年 | 13378篇 |
2016年 | 12210篇 |
2015年 | 14168篇 |
2014年 | 19301篇 |
2013年 | 27983篇 |
2012年 | 36858篇 |
2011年 | 38742篇 |
2010年 | 23213篇 |
2009年 | 22220篇 |
2008年 | 35967篇 |
2007年 | 39014篇 |
2006年 | 39419篇 |
2005年 | 38041篇 |
2004年 | 36645篇 |
2003年 | 35666篇 |
2002年 | 34983篇 |
2001年 | 64581篇 |
2000年 | 66088篇 |
1999年 | 56003篇 |
1998年 | 15033篇 |
1997年 | 13810篇 |
1996年 | 13201篇 |
1995年 | 12443篇 |
1994年 | 11675篇 |
1992年 | 42943篇 |
1991年 | 41442篇 |
1990年 | 40713篇 |
1989年 | 39685篇 |
1988年 | 37070篇 |
1987年 | 36509篇 |
1986年 | 34980篇 |
1985年 | 33161篇 |
1984年 | 24853篇 |
1983年 | 21083篇 |
1982年 | 12687篇 |
1981年 | 11591篇 |
1979年 | 23943篇 |
1978年 | 17084篇 |
1977年 | 14849篇 |
1976年 | 13398篇 |
1975年 | 15281篇 |
1974年 | 18097篇 |
1973年 | 17571篇 |
1972年 | 16822篇 |
1971年 | 15723篇 |
1970年 | 14916篇 |
1969年 | 14354篇 |
1968年 | 13466篇 |
1967年 | 12022篇 |
1966年 | 11262篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
Hyun Jong Choi Jong Ho Moon Yun Nah Lee Hyun Su Kim Ji Su Ha Tae Hoon Lee Sang‐Woo Cha Young Deok Cho Sang‐Heum Park 《Digestive endoscopy》2015,27(7):772-775
Direct peroral cholangioscopy (POC) using an ultra‐slim upper endoscope is one modality of POC for intraductal endoscopic evaluation and treatment of the bile duct. Choledochoduodenostomy (CDS) is one modality of biliary bypass surgery that provides a new route to the bile duct. We carried out direct POC using an ultra‐slim upper endoscope without the use of accessories in 10 patients (four sump syndromes, three bile duct strictures and three intrahepatic duct stones) previously undergoing surgical CDS. Direct POC was successful in all patients. The use of an intraductal balloon catheter was required in one patient for advancement of the endoscope into the bile duct. Distal bile ducts with sump syndromes were cleared using baskets and water irrigation under direct POC. Cholangiocarcinoma was diagnosed in one patient with hilar bile duct stricture after cholangioscopic evaluation and a targeting forceps biopsy under direct POC. Intrahepatic duct stones were successfully extracted after intraductal fragmentation under direct POC. Oozing bleeding occurred during intraductal lithotripsy but stopped spontaneously. Direct POC using an ultra‐slim upper endoscope without the assistance of accessories can easily be carried out in patients undergoing CDS. 相似文献
4.
5.
Improvement in Tricuspid Annular Plane Systolic Excursion with Pulmonary Hypertension Therapy in Pediatric Patients 下载免费PDF全文
6.
7.
8.
9.
10.
E. Niclas Jonsson Rujia Xie Scott F. Marshall Rosalin H. Arends 《British journal of clinical pharmacology》2016,81(4):688-699
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V
1), peripheral volume (V
2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V
1, V
2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V
1 and V
2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit. 相似文献